Smartleaf Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.4K Sell
834
-270
-24% -$9.99K ﹤0.01% 1817
2025
Q4
$46.7K Buy
1,104
+679
+160% +$27.4K ﹤0.01% 1583
2025
Q3
$14.3K Buy
425
+276
+185% +$7.92K ﹤0.01% 1960
2025
Q2
$4.08K Sell
149
-65
-30% -$1.88K ﹤0.01% 2115
2025
Q1
$6.45K Sell
214
-197
-48% -$7.51K ﹤0.01% 2099
2024
Q4
$16.4K Buy
411
+199
+94% +$7.54K ﹤0.01% 1755
2024
Q3
$7.16K Buy
212
+163
+333% +$4.59K ﹤0.01% 1955
2024
Q2
$1.08K Buy
+49
New +$1.03K ﹤0.01% 2403

Other funds holding VCYT

Smartleaf Asset Management's VCYT Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Veracyte (VCYT) stake by 24% in Q1 2026, selling an estimated $9.99K and leaving 834 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Smartleaf Asset Management first reported a position in VCYT in Q2 2024 and has held it in 8 quarters since. The position peaked at $46.7K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Smartleaf Asset Management held 834 shares of Veracyte worth $25.4K as of Q1 2026.
  • Smartleaf Asset Management sold 270 Veracyte shares in Q1 2026, an estimated $9.99K.
  • Veracyte made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1817 holding.
  • Smartleaf Asset Management first reported a position in Veracyte in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Veracyte position peaked at $46.7K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.